Department of Preclinical Development and Validation

Expert reports: GLP safety and effectiveness testing

  • Safety and effectiveness studies of classical pharmaceuticals (small molecules)
  • Safety and effectiveness studies of biopharmaceuticals (therapeutic antibodies, vaccines and viral vectors)
  • Safety and effectiveness studies of ATMPs and ATMP combination products (bioengineered cartilage products and CAR-T cells)
  • Safety and effectiveness studies of medical products according to EN ISO 10993

Further information on the GLP status and available testing systems is provided under the heading Central facilities: GLP Test Facility.